BIBI , N, and MA MALIK. “COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY”. Pakistan Journal of Intensive Care Medicine 5, no. 01 (May 15, 2025): 71. Accessed May 31, 2025. https://pjicm.com/ojs/index.php/home/article/view/71.